CLINICAL_TRIALS
trial_result
· 2022-03-31
Clinical Trial Update: Stem Cells and Stromal Vascular Fraction for Temporomandibular Joint Disease [Phase 1, Phase 2]
Summary
Clinical trial update for stem cells and stromal vascular fraction treatment in temporomandibular joint disorders, currently in Phase 1 and Phase 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: TC Erciyes University | Conditions: Temporomandibular Joint Disorders, Temporomandibular Disorder | Phase 1, Phase 2 | Status: UNKNOWN